Filing Details

Accession Number:
0001209191-19-015629
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-04 16:26:59
Reporting Period:
2019-02-28
Accepted Time:
2019-03-04 16:26:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1427925 Acelrx Pharmaceuticals Inc ACRX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1310803 N Badri Dasu C/O Acelrx Pharmaceuticals, Inc.
351 Galveston Drive
Redwood City CA 94063
Chief Engineering Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-02-28 9,206 $2.81 113,267 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Balance includes non-reportable acquisition of 9,206 shares of Common Stock through the Company's Employee Stock Purchase Plan.